Finance

Lists
002422:SHE
Sichuan Kelun Pharmaceutical Co Ltd
CN¥42.31
+0.26%
(+0.11) 1D
Nov 17, 3:04:24 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002422...
Open
CN¥42.00
High
CN¥42.72
Low
CN¥41.70
Mkt. cap
67.13B
Avg. vol.
18.74M
Volume
9.54M
Dividend
1.40%
Quarterly dividend
CN¥0.15
Ex-dividend date
Oct 21, 2026
P/E ratio
34.11
52-wk high
CN¥52.78
52-wk low
CN¥28.14
EPS
CN¥1.24
Shares outstanding
1.59B
No. of employees
20K
Open
CN¥42.00
High
CN¥42.72
Low
CN¥41.70
Mkt. cap
67.13B
Avg. vol.
18.74M
Volume
9.54M
Dividend
1.40%
Quarterly dividend
CN¥0.15
Ex-dividend date
Oct 21, 2026
P/E ratio
34.11
52-wk high
CN¥52.78
52-wk low
CN¥28.14
EPS
CN¥1.24
Shares outstanding
1.59B
No. of employees
20K
News stories
From web sources and news partners
About Sichuan Kelun Pharmaceutical Co Ltd
CEO-
Employees20.1K
Founded1996
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitekelun.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
5.24B
4.26B
4.58B
4.27B
Cost of goods sold
2.85B
2.33B
2.36B
2.21B
Cost of revenue
2.85B
2.33B
2.36B
2.21B
Research and development expenses
572.64M
586.14M
626.45M
472.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.17B
992.40M
1.11B
1.09B
Operating expense
1.97B
1.66B
1.75B
1.62B
Total operating expenses
4.82B
3.99B
4.11B
3.83B
Operating income
416.66M
271.42M
473.04M
444.99M
Other non operating income
146.54M
82.48M
-86.55M
584.35M
EBT including unusual items
754.91M
441.05M
1.11B
425.95M
EBT excluding unusual items
562.20M
407.20M
405.94M
1.08B
Income tax expense
122.46M
-31.65M
158.57M
77.57M
Effective tax rate
16.22%
-7.18%
14.26%
18.21%
Other operating expenses
233.64M
66.32M
507.56K
55.64M
Net income
501.27M
453.70M
674.07M
339.26M
Net profit margin
9.57%
10.65%
14.72%
7.94%
Earnings per share
-
-
-
-
Interest and investment income
63.65M
76.41M
57.89M
57.57M
Interest expense
-19.09M
-23.12M
-24.71M
-20.47M
Net interest expenses
44.56M
53.29M
33.18M
37.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
739.75M
594.51M
806.81M
768.08M
Gain or loss from assets sale
-5.32M
-
-1.68M
1.68M
Upcoming events
AI content may include mistakes. Learn more
Google apps